Medable vs ChatGPT
Side-by-side comparison of AI visibility scores, market position, and capabilities
Medable raised $304M to build the leading decentralized clinical trial (DCT) platform, enabling remote patient participation, eConsent, and wearable data integration for pharmaceutical trials.
About
Medable provides the technology infrastructure for decentralized clinical trials (DCTs) — enabling pharmaceutical companies to conduct trials where patients participate from home rather than traveling to research sites. The platform covers the full DCT workflow: electronic informed consent (eConsent), remote patient monitoring via wearables, telemedicine visits, electronic clinical outcome assessments (eCOA), and direct-to-patient drug delivery coordination.
ChatGPT surpassed 400M weekly active users in February 2025 and launched GPT-4o with voice, image, and real-time reasoning — the world's most-used AI product.
About
ChatGPT is OpenAI's flagship AI assistant, launched in November 2022 and credited with igniting mainstream consumer adoption of generative AI. It crossed 100 million users in two months — the fastest consumer product to do so in history — and reached 400 million weekly active users by February 2025. Available as a free web and mobile app with a ChatGPT Plus subscription ($20/month) unlocking GPT-4o, advanced voice mode, image generation, and longer context.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.